Beck Mack & Oliver’s Colgate-Palmolive CL Stock Holding History

Beck Mack & Oliver’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$596K	Hold	6,496	–	–	0.01%	131
2026 Q1	$554K	Buy	+6,496	New	+$579K	0.01%	128
2025 Q3	–	Sell	-2,267	Closed	-$206K	–	186
2025 Q2	$206K	Buy	+2,267	New	+$207K	﹤0.01%	175
2024 Q1	–	Sell	-4,576	Closed	-$365K	–	179
2023 Q4	$365K	Buy	+4,576	New	+$344K	0.01%	139
2022 Q2	–	Sell	-4,660	Closed	-$353K	–	178
2022 Q1	$353K	Hold	4,660	–	–	0.01%	152
2021 Q4	$398K	Hold	4,660	–	–	0.01%	153
2021 Q3	$352K	Sell	4,660 -500	-10%	-$39.7K	0.01%	167
2021 Q2	$420K	Hold	5,160	–	–	0.01%	147
2021 Q1	$407K	Hold	5,160	–	–	0.01%	143
2020 Q4	$441K	Sell	5,160 -1,699	-25%	-$140K	0.01%	144
2020 Q3	$529K	Sell	6,859 -200	-3%	-$15.2K	0.02%	136
2020 Q2	$517K	Hold	7,059	–	–	0.02%	137
2020 Q1	$468K	Hold	7,059	–	–	0.02%	137
2019 Q4	$486K	Hold	7,059	–	–	0.02%	147
2019 Q3	$519K	Sell	7,059 -2,200	-24%	-$160K	0.02%	145
2019 Q2	$664K	Sell	9,259 -40,800	-82%	-$2.9M	0.02%	137
2019 Q1	$3.43M	Hold	50,059	–	–	0.12%	68
2018 Q4	$2.98M	Sell	50,059 -3,600	-7%	-$225K	0.12%	70
2018 Q3	$3.59M	Sell	53,659 -3,100	-5%	-$206K	0.11%	74
2018 Q2	$3.68M	Buy	56,759 +610	+1%	+$39.9K	0.12%	72
2018 Q1	$4.03M	Sell	56,149 -235	-0.4%	-$16.9K	0.14%	72
2017 Q4	$4.25M	Buy	56,384 +935	+2%	+$68.3K	0.14%	69
2017 Q3	$4.04M	Hold	55,449	–	–	0.13%	73
2017 Q2	$4.11M	Sell	55,449 -400	-0.7%	-$29.7K	0.14%	73
2017 Q1	$4.09M	Hold	55,849	–	–	0.14%	73
2016 Q4	$3.65M	Sell	55,849 -800	-1%	-$54.9K	0.13%	72
2016 Q3	$4.2M	Sell	56,649 -10,260	-15%	-$758K	0.15%	72
2016 Q2	$4.9M	Hold	66,909	–	–	0.17%	72
2016 Q1	$4.73M	Sell	66,909 -800	-1%	-$53.2K	0.17%	73
2015 Q4	$4.51M	Sell	67,709 -2,818	-4%	-$187K	0.15%	71
2015 Q3	$4.48M	Sell	70,527 -8,300	-11%	-$542K	0.14%	77
2015 Q2	$5.16M	Sell	78,827 -2,500	-3%	-$170K	0.13%	75
2015 Q1	$5.64M	Sell	81,327 -1,500	-2%	-$104K	0.14%	75
2014 Q4	$5.73M	Sell	82,827 -63	-0.1%	-$4.25K	0.14%	76
2014 Q3	$5.41M	Sell	82,890 -500	-0.6%	-$33K	0.13%	77
2014 Q2	$5.69M	Sell	83,390 -1,300	-2%	-$87.1K	0.13%	75
2014 Q1	$5.49M	Sell	84,690 -250	-0.3%	-$15.8K	0.13%	76
2013 Q4	$5.54M	Buy	84,940 +4,856	+6%	+$311K	0.14%	72
2013 Q3	$4.75M	Buy	80,084 +3,524	+5%	+$209K	0.13%	77
2013 Q2	$4.39M	Buy	+76,560	New	+$4.54M	0.12%	77

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Beck Mack & Oliver's CL Position: Q2 2026 in Review

Beck Mack & Oliver held its Colgate-Palmolive (CL) position steady in Q2 2026 at 6,496 shares worth $596K. The position accounts for 0.01% of the portfolio, ranked #131.

Beck Mack & Oliver first reported a position in CL in Q2 2013 and has held it in 40 quarters since. The position peaked at $5.73M in Q4 2014. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Beck Mack & Oliver held 6,496 shares of Colgate-Palmolive worth $596K as of Q2 2026.
Beck Mack & Oliver left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.01% of Beck Mack & Oliver's portfolio in Q2 2026, its #131 holding.
Beck Mack & Oliver first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 40 quarters since.
Beck Mack & Oliver's Colgate-Palmolive position peaked at $5.73M in Q4 2014.
2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.